BioSpace News Archive

Business

Advanced Bifurcation Systems Announces Scott King Joins as Chief of Compliance Ahead of FDA Application

ABS Scott King has joined the leadership team as VP of Regulatory Affairs.

January 5, 2018
·
2 min read
Biotech Beach

Advanced Bifurcation Systems Poised for Breakthrough Success With Strong Patent Protection

A breakthrough stenting technology is being developed by ABS and with 34 patents in place to protect their intellectual property it would be hard to bet against them.

January 5, 2018
·
5 min read
GeneNews Announces Letter to Shareholders From CEO

GeneNews released a Letter to Shareholders updating current activities and outlining its corporate strategy for 2018.

January 5, 2018
·
4 min read
Biotech Beach

ABS Release: Major Heart Treatment to Eliminate Thousands of Open Heart Surgeries

Advanced Bifurcation Systems is developing a new procedure that could potentially eliminate the need for open-heart surgery in thousands of patients every year.

January 5, 2018
·
4 min read
Biotech Beach

ABS Sets Their Sights on $20M in New Funding Led by New CFO

The new goal was announced in conjunction with the appointment of new CFO Ken Richards, who brings with him a strong background in both debt and equity financing.

January 5, 2018
·
4 min read
BioForest

Immusoft Closes First Part of Series B Financing, New CEO to Lead Gene Therapy Company

The round is expected to provide Immusoft the funding it needs to complete its Phase I/II clinical trial in MPS-I and advance its pipeline.

January 5, 2018
·
4 min read
Business

ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor

ZOLL announced today the receipt of a sole source contract from the Defense Logistics Agency to supply Propaq® M deployable vital signs monitors to the U.S. Air Force and the U.S. Army.

January 5, 2018
·
4 min read
Business

Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook

Amarin plans to discuss these results and expectations with investors in connection with the 36th Annual J.P. Morgan Healthcare Conference.

January 5, 2018
·
18 min read
Business

The Cooper Companies Declares Cash Dividend - Jan. 5, 2018

The Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2018, to stockholders of record on January 23, 2018.

January 5, 2018
·
1 min read
Vitruvias Therapeutics Inc. Completes Series A Preferred Financing Led by JW Asset Management and Perceptive Advisors

Vitruvias Therapeutics, a private generic pharmaceutical company with a focus on sterile injectables, announced today the completion of a $11.5 million Series A preferred financing.

January 5, 2018
·
3 min read